Use of intravenous tissue plasminogen activator and hospital costs for patients with acute ischaemic stroke aged 18–64 years in the USA

INTRODUCTION: Intravenous tissue plasminogen activator (IV tPA) is a globally recommended treatment for patients with acute ischaemic stroke. We examined IV tPA use among patients aged 18–64 years with a primary diagnosis of acute ischaemic stroke in the USA and inpatient costs per hospitalisation b...

Descripción completa

Detalles Bibliográficos
Autores principales: Joo, Heesoo, Wang, Guijing, George, Mary G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990217/
https://www.ncbi.nlm.nih.gov/pubmed/27547449
http://dx.doi.org/10.1136/svn-2015-000002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990217/
https://www.ncbi.nlm.nih.gov/pubmed/27547449
http://dx.doi.org/10.1136/svn-2015-000002

Ejemplares similares